Online Only Articles

Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia

Department of Internal Medicine III, Ulm University, Ulm, Germany
Department of Internal Medicine III, Ulm University, Ulm, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany
Department of Internal Medicine III, Ulm University, Ulm, Germany
AbbVie, North Chicago, IL, USA
Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany
Department of Internal Medicine III, Ulm University, Ulm, Germany
Department of Internal Medicine III, Ulm University, Ulm, Germany;Cooperation unit “Mechanisms of Leukemogenesis”, Deutsches Krebsforschungszentrum DKFZ, Heidelberg, Germany
Department of Internal Medicine III, Ulm University, Ulm, Germany;Department for Hematology, Oncology and Rheumatology, Saarland University Medical School, Homburg/Saar, Germany
Vol. 104 No. 9 (2019): September, 2019 https://doi.org/10.3324/haematol.2019.222588